SINGLE DOSE BIOEQUIVALENCE BETWEEN LEVETIRACETAM 2 x 750 MG XR TABLETS AND 3 x 500 MG XR TABLETS AND FOOD EFFECT ON 2 x 750 MG XR TABLETS IN HEALTHY SUBJECTS

被引：0
|
作者：
Otoul, Christian [1 ]
Rouits, Elisabeth [1 ]
Burton, I. [2 ]
Guenole, E. [3 ]
Troenaru, Mona [1 ]
Valgaeren, A. [1 ]
Boulanger, P. [1 ]
Sargentini-Maier, Maria Laura [1 ]
机构：
[1] UCB Pharma SA, Braine Lalleud, Belgium
[2] SGS Life Sci Serv, Dept Pharmacokinet, Wavre, Belgium
[3] Therapharm Rech, Caen, France
来源：
EPILEPSIA | 2008年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：446 / 446
页数：1
相关论文
共 50 条
  • [1] Glueophage extended release (XR) 750-mg tablets and glueophage XR 500-mg tablets are bioequivalent in healthy fed subjects
    Xiang, G
    Xie, JD
    Moore, K
    Uderman, H
    Reeves, R
    Turner, K
    DIABETES, 2003, 52 : A108 - A108
  • [2] Glucophage extended release (XR) 750-mg tablets and Glucophage XR 500-mg tablets are bioequivalent in healthy fasting subjects
    Xiang, G
    Xie, JD
    Moore, K
    Uderman, H
    Reeves, R
    Turner, K
    DIABETES, 2003, 52 : A109 - A109
  • [3] Pharmacokinetics of levetiracetam XR 500 mg tablets
    Rouits, Elisabeth
    Burton, Ingrid
    Guenole, Evelyne
    Troenaru, Mona-Mihaela
    Stockis, Armel
    Sargentini-Maier, Maria Laura
    EPILEPSY RESEARCH, 2009, 84 (2-3) : 224 - 231
  • [4] Levetiracetam: relative bioavailability and bioequivalence of 10% oral solution (750 Mg) and 750 Mg tablets
    Coupez, R
    Straetemans, R
    Sehgal, G
    Armel, S
    Lu, Z
    EPILEPSIA, 2004, 45 : 139 - 139
  • [5] Levetiracetam: Relative bioavailability and bioequivalence of 10% oral solution (750 mg) and 750 mg tablets
    Coupez, R
    Straetemans, R
    Sehgal, G
    Stockis, A
    Lu, Z
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S112 - S112
  • [6] Levetiracetam: Relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets
    Coupez, R
    Straetemans, R
    Sehgal, G
    Stockis, A
    Lu, ZH
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (12): : 1370 - 1376
  • [7] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects
    David W. Boulton
    Charles H. Smith
    L. Li
    Jian Huang
    Angela Tang
    Frank P. LaCreta
    Clinical Drug Investigation, 2011, 31 : 619 - 630
  • [8] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects
    Boulton, David W.
    Smith, Charles H.
    Li, L.
    Huang, Jian
    Tang, Angela
    LaCreta, Frank P.
    CLINICAL DRUG INVESTIGATION, 2011, 31 (09) : 619 - 630
  • [9] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects
    Anders Gummesson
    Haiyan Li
    Michael Gillen
    John Xu
    Mohammad Niazi
    Boaz Hirshberg
    Clinical Drug Investigation, 2014, 34 : 763 - 772
  • [10] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects
    Gummesson, Anders
    Li, Haiyan
    Gillen, Michael
    Xu, John
    Niazi, Mohammad
    Hirshberg, Boaz
    CLINICAL DRUG INVESTIGATION, 2014, 34 (11) : 763 - 772
12345